Molecule Details
| InChIKey | AKJHMTWEGVYYSE-FXILSDISSA-N |
|---|---|
| Canonical SMILES | CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.9 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB05076 |
|---|---|
| Drug Name | Fenretinide |
| CAS Number | 65646-68-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. |
Categories: Alkenes Anticarcinogenic Agents Antineoplastic Agents Biological Factors Carotenoids Compounds used in a research, industrial, or household setting Cyclohexanes Cyclohexenes Cycloparaffins Hydrocarbons, Acyclic Pigments, Biological Polyenes Protective Agents Retinoids Terpenes
Cross-references: BindingDB: 50092055 ChEBI: 42588 CHEMBL7301 ChemSpider: 4450416 D04162 PDB: FEN PubChem:5288209 PubChem:175426938 Wikipedia: Fenretinide ZINC: ZINC000003871023
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P02753 | RBP4 | Retinol-binding protein 4 | binder | carriers |